RUNCORN, UK – Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific STP 420ES Tissue Processor for high-throughput tissue processing. This new tissue processor enables faster turnaround times for same-day diagnosis and leaner workflows through operational flexibility. Using a dual chamber design, which features unique rotational agitation that increases […]

HOLLISTON, Mass. – Harvard Bioscience, Inc. (Nasdaq:HBIO – News), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the preclinical business unit of CMA Microdialysis AB through a purchase of assets. CMA Microdialysis AB is a privately held […]

San Jose, CA – Persistent Systems (BSE & NSE: PERSISTENT), a leader in software product development services, today announced that they are partnering and co-investing with Life Technologies Corporation (NASDAQ: LIFE), a global biotechnology tools company providing premier systems, consumables, and services in the molecular research and diagnostics space. As part of the collaboration, Persistent […]

Austin, Texas – Asuragen, Inc. announces results from an evaluation of a breakthrough PCR technology that determines the methylation status of the fragile X gene. The study was published in collaboration with researchers at the University of California Davis M.I.N.D. Institute in the June issue of Genetics in Medicine, the official journal of the American […]

Penzberg, Germany – During the last weeks, there has been a significant increase in the number of cases of bloody diarrhea associated with hemolytic-uremic syndrome (HUS) caused by enterohaemorrhagic Escherichia coli (EHEC). To date, more than 3,400 laboratory confirmed EHEC and HUS cases have been reported, 39 of them with fatal outcome (Robert Koch Institute’s […]

Constance, Germany – In conjunction with several Central European prenatal centers, scientists at GATC Biotech AG and LifeCodexx AG have begun the clinical validation study of a non-invasive, prenatal diagnostic test based on next generation sequencing. The test detects fetal trisomy 21 (Down’s syndrome) and is based on the sequencing cell-free fetal DNA from maternal […]

AUSTIN, Texas – Luminex Corporation (NASDAQ: LMNX) today announced the completion of its acquisition of privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications, for $34 million in cash. Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue. On […]

CHICAGO – Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care, announced today that it has acquired MarketLab, Inc. Water Street’s investment in MarketLab is the firm’s fourth in the specialty healthcare distribution sector. The acquisition expands Water Street’s current group of health care companies specializing in distribution, life sciences, […]

Milford, Mass. – SeraCare Life Sciences (Nasdaq: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced it has received CE marking for its ACCURUN® 644 Control for Cystic Fibrosis Testing, now available in Europe. After serving as a highly […]

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced that it has received a funding award of £1.16 million from the UK government-backed Technology Strategy Board. As part of the project, OGT will develop a tumour profiling assay based on targeted panel enrichment and next […]